The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial

• Main Authors: Farzaneh Dastan (Author), Hamidreza Jamaati (Author), Saghar Barati (Author), Shahrzad Varmazyar (Author), Sahar Yousefian (Author), Elmira Niknami (Author), Payam Tabarsi (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Tocilizumab and baricitinib are considered standard treatments for hospitalized COVID-19 patients with an inflammatory status. However, the effects of co-administering these medications aiming for more rapid patient recovery are controversial among practitioners. The potential benefits i...